Latest Regulatory Progress News

Sky Metals has unveiled a significant Mineral Resource Estimate upgrade for its Tallebung project, lifting tin and tungsten inventories substantially and introducing a maiden silver resource. This positions Tallebung as a large-scale, shallow open-pit opportunity with promising metallurgical and development prospects.

Infini Resources has completed a high-resolution airborne radiometric survey at its Portland Creek Uranium Project in Newfoundland, enhancing geological targeting ahead of a planned Phase 3 diamond drilling campaign in Q3 2026.

Noxopharm has taken a key regulatory step by requesting a pre-IND meeting with the US FDA for its autoimmune drug candidate SOF-SKN, aiming to smooth the path for clinical development and boost its commercial appeal.

Lakes Blue Energy is positioning its Wombat Gas Project as a key contributor to Victoria's energy security and emerging AI infrastructure, with a conceptual study projecting a post-tax NPV10 of A$605 million and first gas in early 2029.

Algorae Pharmaceuticals has been appointed as a supplier under a NSW Health public hospital supply contract, marking a strategic milestone despite uncertain immediate revenue impact.

OncoSil Medical secures a spot in the PALACROS consortium, advancing its OncoSil™ device through a cost-efficient Phase II trial targeting unresectable locally advanced pancreatic cancer.

Kinetiko Energy has approved a Field Development Plan marking its shift from exploration to production at the Brakfontein gas project in South Africa, aiming to fast-track gas output and secure strategic funding.

Imugene Limited reports a complete response in the first patient treated with azer-cel combined with BTK inhibitors in its Phase 1b trial, highlighting potential for resistant follicular lymphoma.

Brazilian Critical Minerals releases a robust Bankable Feasibility Study for its Ema Rare Earth Project, highlighting a US$1.47 billion post-tax NPV and a swift 0.5-year payback period, underpinned by low capital and operating costs.

Audalia Resources (ASX: ACP) is seeking to raise $450,000 through a placement of 15 million shares at 3 cents each, aiming to fund the Medcalf project’s progression and shore up working capital.

Australian Rare Earths (ASX: AR3) has announced a maiden Ore Reserve of 26 million tonnes at 920 ppm TREO for its Koppamurra Rare Earths Project, underpinned by a robust Pre-Feasibility Study delivering an A$858 million post-tax NPV and a rapid payback of less than one year.

The a2 Milk Company has announced a $300 million fully franked special dividend following regulatory clearance in China to rebrand infant formula products under its a2 label.